Innovative Solutions for Neurological Health
Pioneering the Future of GPCR Research
At Axowit, we are dedicated to advancing pharmaceutical research to improve neurological health through cutting-edge GPCR innovations.
Our Research Methodology
Discover the meticulous processes that drive our groundbreaking pharmaceutical developments.
1
Target Characterization
GPCRs are key drug targets, with over 150 orphan receptors lacking known ligands. Our proprietary technology precisely validates these targets, ensuring their relevance in disease biology for enhanced therapeutic success.
2
Unique Architecture
BrioNex designs best-in-class compounds by leveraging deep expertise in biology, chemistry, and a custom-built GPCR library. Our AI-based approach meticulously develops therapeutic candidates at an unprecedented pace.
3
Bridging Discovery to Development
After identifying promising candidates, our expert team designs and conducts rigorous safety evaluations and proof-of-concept studies, enabling informed decisions on program advancement.